Sort
40,608 grants matching “prostate cancer”
Controlled Release of Macromolecules
$390,000Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2017 · EB
Optimizing telehealth across the cancer care continuum during the COVID-19 national emergency
$390,000Karen E Knudsen · Thomas Jefferson University · P30 · FY2020 · CA
Emotion-Regulation, Inflammatory Processes, and Depression in Prostate Cancer Sur
$390,000Michael A Hoyt · Hunter College · SC1 · FY2016 · CA
Emotion-Regulation, Inflammatory Processes, and Depression in Prostate Cancer Sur
$390,000Michael A Hoyt · Hunter College · SC1 · FY2017 · CA
Collaborative Research: Design of Multifunctional Doubly-Fusogenic Liposomes to Deliver Therapeutics and Diagnostics
$390,000Stavroula Sofou · Rutgers University New Brunswick · · FY2012 · MPS
CLINICAL ULTRASONIC CHARACTERIZATION OF THE PROSTATE
$389,951Riverside Research Institute · R01 · FY2004 · CA
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$389,940David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · CA
Tumor Cell Biology Training Program
$389,890Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2013 · CA
Mapping a clinically significant internalizing tumor epitope space.
$389,886Bin Liu · University Of California, San Francisco · R01 · FY2009 · CA
Cancer Care and Outcomes for Disabled Medicare Patients
$389,835Beth Israel Deaconess Medical Center · R01 · FY2004 · CA
Statistical Methods for Prospective Evaluation of Biomarkers
$389,827Yingye Zheng · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Epigenetics/Translational Biomarkers (ETB) Core
$389,820Christiane V. Lohr · Texas A&M University Health Science Ctr · P01 · FY2014 · CA
Targeting the colchicine binding site in tubulin for cancer therapy
$389,817Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Targeting the colchicine binding site in tubulin for cancer therapy
$389,817Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$389,781Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2016 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$389,781Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2017 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$389,781Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2015 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$389,781Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2013 · CA
Quantitative C-arm Fluoroscopy - Prostate Brachytherapy
$389,676Everette C Burdette · Burdette Medical Systems, Inc. · R44 · FY2008 · CA
Effectors of protein kinase C-mediated tumor progression
$389,662Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2020 · CA
Effectors of protein kinase C-mediated tumor progression
$389,662Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2017 · CA
Effectors of protein kinase C-mediated tumor progression
$389,662Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2018 · CA
Effectors of protein kinase C-mediated tumor progression
$389,662Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2016 · CA
Role of PALB2 in the DNA Damage Response and Cancer Suppression
$389,655Bing Xia · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA
$389,640University Of Nairobi · · FY2022 · Defense Health Agency